Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,974,121
-$1,788,063 QoQ
Shares Held
275,209
-29.6% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#107
of 739 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. EXEL ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
505,160 | $35,376,354 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,839 | $26,088,290 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
120,122 | $22,496,448 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
83,679 | $20,482,108 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
556,385 | $18,577,695 | |
| 6 | INSM |
INSMED Inc
|
156,553 | $16,691,680 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
275,712 | $15,164,160 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
275,209 | $14,974,121 |
All Filings in EXEL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,974,121 | 275,209 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,762,184 | 390,818 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,572,472 | 218,400 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,843,092 | 68,840 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $27,748,315 | 629,499 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,488,733 | 121,580 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $19,818,361 | 595,146 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $11,086,852 | 427,239 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,612,614 | 160,775 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $344,915 | 14,535 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,262,134 | 219,347 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $9,855,092 | 451,034 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,423,334 | 231,467 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,945,066 | 254,769 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $609,054 | 37,971 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,567,411 | 163,738 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,556,279 | 122,780 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,500,323 | 66,181 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $518,987 | 28,391 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $278,715 | 12,338 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $376,553 | 18,762 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,893,432 | 77,441 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $3,043,847 | 128,216 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,016,341 | 59,021 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||